Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Complete response to the combination of Lenvatinib and Pembrolizumab in an advanced hepatocellular carcinoma patient: a case report

Fig. 1

CT of the abdomen showing the segment 3 liver lesions at diagnosis. a The characteristics of liver mass in plain scan; b Liver mass in arterial phase; c Liver mass in portal phase; d Multiple collateral circulations; e Partial thrombosis of the left portal vein in arterial phase; f Partial thrombosis of the left portal vein in portal phase

Back to article page
\